Eslicarbazepine (Epilepsy) updated on 04-22-2025

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)6.89 [0.49, 96.82]19%2 studies1238not evaluable ROB-
Major congenital malformations6.89 [0.49, 96.82]19%2 studies1238not evaluable ROB-